Carmen Bozic sold $1.1M of Vertex Pharmaceuticals Incorporated (VRTX)

Executed Feb 27, disclosed Mar 3, 4 days later.

Value, as filed

$1.1M

2,329 sh × $480.31

Executed

Feb 27

the trade date, as filed

Disclosed

Mar 3

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

CB Carmen Bozic EVP and CMO profile →

Carmen Bozic (EVP and CMO) filed 10 Form 4 reports in the trailing twelve months (0 purchases, 10 sales), most often in Vertex Pharmaceuticals Incorporated (VRTX). The largest single filing was $3.1M of VRTX (6,988 sh × $450.00, as filed), executed May 12.

The name

VRTX Vertex Pharmaceuticals Incorporated VRTX · Healthcare · 91 filings in 24 months ticker →

Healthcare · Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Carmen Bozic in VRTX

VRTXSALE Vertex Pharmaceuticals Incorporated $288K
596 sh × $482.50
Exec Jun 26
Filed Jun 30 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated $471K
1,020 sh × $462.17
Exec Jun 18
Filed Jun 23 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated $1.8M
4,062 sh × $450.00
Exec Jun 15
Filed Jun 17 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated $785K
1,745 sh × $450.00
Exec Jun 5
Filed Jun 9 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated $888K
1,974 sh × $450.00
Exec May 29
Filed Jun 2 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated $614K
1,354 sh × $453.45
Exec May 15
Filed May 19 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated $3.1M
6,988 sh × $450.00
Exec May 12
Filed May 14 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated $1.1M
2,329 sh × $450.95
Exec Mar 27
Filed Mar 31 · 5:30 PM ET